NIKTIMVO
NDC 50881-034, axatilimab-csfr, injection, from Incyte Corporation.
- Product NDC
- 50881-034
- Status
- Listed
- Labeler
- Incyte Corporation
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761411
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50881-034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AXATILIMAB9 mg/.18mL
Pharmacologic classes
Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]; Colony Stimulating Factor-1 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50881-034-12 | 50881003412 | 1 VIAL, SINGLE-USE in 1 CARTON (50881-034-12) / .18 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/bb6dba23-e7a6-4765-a1e6-b9e277ce0381Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50881-034
Use it
Look up 50881-034 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50881-034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50881-034. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.